|
|
News Breaks | | | | September 11, 2012 | | 08:42 EDT |  | INFA | Informatica risk/reward ratio excellent, says Roth Capital
After speaking with Informatica's CEO, Roth Capital is more confident in the company's outlook. Roth notes that Informatica reported weaker than expected Q2 results, but was able to bounce back effectively from the 2008-2009 macro crisis. The firm raised its price target on the shares to $42 from $38 and maintains a Buy rating. | |
|
News For INFA From The Last 14 Days Check below for free stories on INFA the last two weeks. |
|
|
| May 14, 2013 | | 17:48 EDT |  | INFA | Lone Pine gives quarterly update on stakes
NEW STAKES: Valeant Pharmaceuticals (VRX), Virgin Media (VMED), Thermo Fisher Scientific (TMO), CME Group (CME), and Liberty Media (LMCA). INCREASED STAKES: Mead Johnson Nutrition (MJN), News Corp (NWSA), Intuitive Surgical (ISRG), Monsanto (MON), and Qualcomm (QCOM). DECREASED STAKES: Cognizant Technology Solutions (CTSH), Equinix (EQIX), Ralph Lauren (RL), Disney (DIS), and Oceaneering International (OII). LIQUIDATED STAKES: Facebook (FB), Crown Castle (CCI), Accretive Health (AH), Informatica (INFA), and NetEase (NTES). | |
|
|
|
|
|
|
